Home / Import refusals / 1FX-2233101-0/50002/2

FDA Import Refusal 1FX-2233101-0/50002/2 — Cipla Pvt Ltd

Cipla Pvt Ltd — FEI 3012215569

The FDA refused shipment 1FX-2233101-0/50002/2 from Cipla Pvt Ltd (India) on Apr 7, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Apr 7, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61JDA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Other import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.